Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
Iris N. Pardieck, Tetje C. van der Sluis, Esmé T.I. van der Gracht, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14
Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile
Xian Tang, Wei Zhang, Zheng Zhang
Vaccines (2025) Vol. 13, Iss. 2, pp. 135-135
Open Access | Times Cited: 1
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Xiantao Zhang, Shijian Wu, Jie Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 25
Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
Takuya Tada, Ju-Yi Peng, Belinda M. Dcosta, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 13
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
Patrick O. Azevedo, Natália Satchiko Hojo-Souza, Lídia Faustino, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies
Juan Shi, Jian Zheng, Xiujuan Zhang, et al.
JCI Insight (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 4
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R. Melo‐Silva, Lingjuan Tang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1790-1804
Open Access | Times Cited: 4
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 10
Open Access | Times Cited: 19
SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
Gang Yang, Junxiang Wang, Ping Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells
Mengfei Chen, Vanessa Venturi, C. Mee Ling Munier
Biology (2023) Vol. 12, Iss. 7, pp. 1035-1035
Open Access | Times Cited: 10
Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity
Xiaotong Zheng, Rong Yang, Yuxiu Zhao, et al.
Virology (2024) Vol. 594, pp. 110050-110050
Closed Access | Times Cited: 3
Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
Erica L. Stewart, Claudio Counoupas, Matt D. Johansen, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1405-1415
Open Access | Times Cited: 15
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice
Yudong Wang, Busen Wang, Zhenghao Zhao, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 763-763
Open Access | Times Cited: 8
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
Hao Zhou, Ping Leng, Yang Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 15, pp. 2456-2470
Closed Access | Times Cited: 2
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants
Renee L. Hajnik, Jessica A. Plante, Srinivasa Reddy Bonam, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
Camille Bigenwald, Yacine Haddad, Cassandra Thélémaque, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Antibody Responses to the SARS-CoV-2 Ancestral Strain and Omicron Variants in Moderna mRNA-1273 Vaccinated Active-Duty US Navy Sailors and Marines
Peifang Sun, Corey A. Balinsky, Le Jiang, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 149-159
Open Access | Times Cited: 7
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Brandon Carter, Pinghan Huang, Ge Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles
Francesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration
Mohammed O. Abdelaziz, Martin Raftery, Julian Weihs, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease
Jingyi Yan, Chandrashekar Ravenna Bangalore, Negin Nikouyan, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 540-555
Open Access | Times Cited: 1
A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice
Yang Song, Hongqiao Hu, Kang Xiao, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 4
Computational Methods for Single-Cell Proteomics
Sophia M. Guldberg, Trine Line Hauge Okholm, Elizabeth McCarthy, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 47-71
Open Access | Times Cited: 4
Animal models for COVID-19 and tuberculosis
Björn Corleis, Max Bastian, Donata Hoffmann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top